May 20, 2008
Story Timeline: 198 days
MONTVALE, N.J., May 20 /PRNewswire/ -- Despite the clear benefits of lipid-modifying drugs, current management of dyslipidemia remains suboptimal, as discussed in a new supplement to The Journal of Family Practice. "High-dose statin therapy: Benefits and safety in aggressive lipid lowering"...
[read full story]